![Per Grufman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Per Grufman
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Directeur Général | 20/01/2023 | - |
Historique de carrière de Per Grufman
Anciens postes connus de Per Grufman
Sociétés | Poste | Début | Fin |
---|---|---|---|
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Karolinska Institutet | Directeur/Membre du Conseil | - | - |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Directeur Technique/Scientifique/R&D | - | 27/11/2009 |
Corporate Officer/Principal | 27/11/2009 | - | |
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Directeur Technique/Scientifique/R&D | - | 27/11/2009 |
Corporate Officer/Principal | 27/11/2009 | - |
Formation de Per Grufman
Karolinska Institutet | Doctorate Degree |
University of Stockholm | Graduate Degree |
Statistiques
Internationale
Suède | 5 |
Royaume-Uni | 3 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Health Technology |
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Per Grufman
- Expérience